Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 32702599)

  • 1. Comprehensive analysis of the prognostic value and immune function of chemokine-CXC receptor family members in breast cancer.
    Lyu L; Zheng Y; Hong Y; Wang M; Deng Y; Wu Y; Xu P; Yang S; Wang S; Yao J; Zhang D; Guo Y; Lyu J; Dai Z
    Int Immunopharmacol; 2020 Oct; 87():106797. PubMed ID: 32702599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CXCR4 and CXCR3 are two distinct prognostic biomarkers in breast cancer: Database mining for CXCR family members.
    Guo K; Feng G; Yan Q; Sun L; Zhang K; Shen F; Shen M; Ruan S
    Mol Med Rep; 2019 Dec; 20(6):4791-4802. PubMed ID: 31702806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression profile and prognostic value of CXCR family members in head and neck squamous cell carcinoma.
    Shen Y; Zhou C; Cao Y; Li Q; Deng H; Gu S; Wu Y; Shen Z
    World J Surg Oncol; 2022 Aug; 20(1):259. PubMed ID: 35978426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of DRP1 as a prognostic factor correlated with immune infiltration in breast cancer.
    Liu B; Fan Y; Song Z; Han B; Meng Y; Cao P; Tan K
    Int Immunopharmacol; 2020 Dec; 89(Pt B):107078. PubMed ID: 33049497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of Potential Therapeutic Targets and Prognostic Markers of Ovarian Cancer by Bioinformatics Analysis.
    Zhang J; Huang S; Quan L; Meng Q; Wang H; Wang J; Chen J
    Biomed Res Int; 2021; 2021():8883800. PubMed ID: 33829065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive analysis of CXCR family members in lung adenocarcinoma with prognostic values.
    Hu LT; Deng WJ; Chu ZS; Sun L; Zhang CB; Lu SZ; Weng JR; Ren QS; Dong XY; Li WD; Li XB; Du YT; Li Y; Wang WQ
    BMC Pulm Med; 2022 Jun; 22(1):259. PubMed ID: 35768814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrated analysis identifies TfR1 as a prognostic biomarker which correlates with immune infiltration in breast cancer.
    Chen F; Fan Y; Hou J; Liu B; Zhang B; Shang Y; Chang Y; Cao P; Tan K
    Aging (Albany NY); 2021 Sep; 13(17):21671-21699. PubMed ID: 34518441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the Prognostic Values of the CXCR1-7 in Clear Cell Renal Cell Carcinoma (ccRCC) Microenvironment.
    Wu Z; Zhang Y; Chen X; Tan W; He L; Peng L
    Front Mol Biosci; 2020; 7():601206. PubMed ID: 33324682
    [No Abstract]   [Full Text] [Related]  

  • 9. OLR1 is a prognostic factor and correlated with immune infiltration in breast cancer.
    Sun X; Fu X; Xu S; Qiu P; Lv Z; Cui M; Zhang Q; Xu Y
    Int Immunopharmacol; 2021 Dec; 101(Pt B):108275. PubMed ID: 34688153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SOX13 is a novel prognostic biomarker and associates with immune infiltration in breast cancer.
    Gao T; Jiang B; Zhou Y; He R; Xie L; Li Y
    Front Immunol; 2024; 15():1369892. PubMed ID: 38707897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic analysis of the expression and prognostic value of ITPR1 and correlation with tumor infiltrating immune cells in breast cancer.
    Han B; Zhen F; Zheng XS; Hu J; Chen XS
    BMC Cancer; 2022 Mar; 22(1):297. PubMed ID: 35313846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NEFM DNA methylation correlates with immune infiltration and survival in breast cancer.
    Li D; Zhao W; Zhang X; Lv H; Li C; Sun L
    Clin Epigenetics; 2021 May; 13(1):112. PubMed ID: 34001208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioinformatics identification of CCL8/21 as potential prognostic biomarkers in breast cancer microenvironment.
    Chen B; Zhang S; Li Q; Wu S; He H; Huang J
    Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33146700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive analysis of the expression, prognostic significance, and regulation pathway of G2E3 in breast cancer.
    Shen Y; Xue J; Yu J; Jiang Y; Bu J; Zhu T; Gu X; Zhu X
    World J Surg Oncol; 2022 Dec; 20(1):398. PubMed ID: 36517818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of Potential Therapeutic Targets Among CXC Chemokines in Breast Tumor Microenvironment Using Integrative Bioinformatics Analysis.
    Chen E; Qin X; Peng K; Xu X; Li W; Cheng X; Tang C; Cui Y; Wang Z; Liu T
    Cell Physiol Biochem; 2018; 45(5):1731-1746. PubMed ID: 29495008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrative analysis of prognostic value and immune infiltration of spindle and kinetochore-associated family members in breast cancer.
    Ding J; He X; Wang J; Cao G; Chen S; Yuan L; Chen B; Xiong M
    Bioengineered; 2021 Dec; 12(2):10905-10923. PubMed ID: 34845974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of chemokine receptor CXCR3 on tumor-infiltrating lymphocyte recruitment associated with favorable prognosis in advanced gastric cancer.
    Li K; Zhu Z; Luo J; Fang J; Zhou H; Hu M; Maskey N; Yang G
    Int J Clin Exp Pathol; 2015; 8(11):14725-32. PubMed ID: 26823797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of CXC chemokine ligand 4/CXC chemokine receptor 3-B in breast cancer progression.
    Saahene RO; Wang J; Wang ML; Agbo E; Song H
    Biotech Histochem; 2019 Jan; 94(1):53-59. PubMed ID: 30264586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CXC family of chemokines as prognostic or predictive biomarkers and possible drug targets in colorectal cancer.
    Cabrero-de Las Heras S; Martínez-Balibrea E
    World J Gastroenterol; 2018 Nov; 24(42):4738-4749. PubMed ID: 30479461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and clinical prognostic value of CYB561 in breast cancer.
    Zhou X; Shen G; Ren D; Guo X; Han J; Guo Q; Zhao F; Wang M; Dong Q; Li Z; Zhao J
    J Cancer Res Clin Oncol; 2022 Aug; 148(8):1879-1892. PubMed ID: 35486183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.